Virtual reality powered by muscle signals could transform stroke rehab

NCT ID NCT07705256

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This pilot study tests whether a virtual-reality system controlled by muscle activity can help improve arm and hand movement in people recovering from stroke or spinal cord injury. Participants use a wearable device that detects muscle signals through sensors on the skin and provides visual and vibration feedback during upper-limb exercises. A smaller sub-study also adds electrical stimulation to help activate muscles. The study measures changes in movement ability and explores which biological or movement-related markers are linked to recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a wearable device that uses surface EMG sensors to detect muscle activity and provides visual and vibrotactile feedback during virtual-reality rehabilitation exercises
What this could lead to
If successful, this approach could offer a new, engaging way to improve arm and hand function during rehabilitation after stroke or spinal cord injury.
What could go wrong
This is a small pilot study with only 20 participants, so results may not apply to everyone. The device is still experimental, and it is unclear how much it will improve movement compared to standard therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES (COMPLETE AND INCOMPLETE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Charing Cross Hospital

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.